Clinical trial
ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR…
NCT00180518 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00180518 |
|---|---|
| Title | ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial" |
| Official title | Prospective, Non-Randomized, Multi-Center, Single-Arm Trial to Assess Safety & Efficacy of the Acculink Carotid Stent System With the Accunet Embolic Protection System in High-Risk Patients With Carotid Artery Lesions. |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Carotid Atherosclerosis, Carotid Artery Disease |
| Intervention type | Device |
| Interventions | Over-the-wire & Rapid Exchange ACCULINK (tm) Carotid Stent & ACCUNET (tm) embolic protection system |
| Enrollment | 581 |
| Start date | May 1, 2000 |
| Primary completion | Oct 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 12, 2008 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: